ResearchSafe

Is the hype around PE 22-28 actually grounded?

Posted by biohacker_priya in Research & News - 1 points, 0 comments.

I was reading up on the spadin derived peptide PE 22-28 and the claims about it blocking the TREK-1 potassium channel to trigger rapid neurogenesis are pretty wild. The idea that it could produce antidepressant effects faster than SSRIs in animal models sounds promising, but I am skeptical.

Since it is still preclinical, we have basically zero human safety data to lean on. I have always been cautious about jumping on these things before we know the long term side effects, especially when it comes to messing with brain plasticity. For me, the risk of the unknown usually outweighs the potential for a quick fix.

I keep seeing it pop up in longevity and cognitive circles, but I am not convinced yet. It feels like another one of those compounds where the mouse data is extrapolated too quickly to humans... Does anyone here have actual experience with this or is it just theoretical for now? I would be curious to know if anyone has tracked their mood or cognitive function on it, or if we are all just guessing based on the /peptides/pe-22-28 info... Thanks for any insight.

Community discussion - research and educational context only. Not medical advice.